ABCL
AbCellera Biologics Inc.
Nasdaq Pharmaceutical Preparations Large accelerated filer

Key Financials

Net Income
$-146412000
↑ 10.1%
Revenue
$75.1M
↑ 160.6%
Operating Income
$-217103000
↑ 31.0%
Total Assets
$1.4B
↓ 0.3%
Cash & Equivalents
$128.5M
↓ 17.8%
Total Liabilities
$390.0M
↑ 28.1%
EPS (Diluted)
$-0.49
↑ 10.9%
Shareholders' Equity
$966.9M
↓ 8.4%

Recent SEC Filings

Form Type Filed Date Link
4 3/2/2026 View on SEC
4 2/27/2026 View on SEC
4 2/27/2026 View on SEC
S-8 2/24/2026 View on SEC
10-K 2/24/2026 View on SEC
8-K 2/24/2026 View on SEC
8-K 1/14/2026 View on SEC
4 1/5/2026 View on SEC
4 1/5/2026 View on SEC
4 1/5/2026 View on SEC

Company Information

Field Value
Ticker ABCL
Company Name AbCellera Biologics Inc.
CIK 1703057
Sector Pharmaceutical Preparations
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation A1
Phone (604) 559-9005